Lindbrook Capital, LLC Roivant Sciences Ltd. Transaction History
Lindbrook Capital, LLC
- $1.09 Billion
- Q4 2024
A detailed history of Lindbrook Capital, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 597 shares of ROIV stock, worth $6,411. This represents 0.0% of its overall portfolio holdings.
Number of Shares
597
Previous 799
25.28%
Holding current value
$6,411
Previous $9,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$707 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$666 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$513 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$473 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$380 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.57B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...